{{Rsnum
|rsid=5110
|Gene=APOA4
|Chromosome=11
|position=116820918
|Orientation=plus
|GMAF=0.03306
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=APOA4
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 81.4 | 18.6 | 0.0
| HCB | 98.5 | 1.5 | 0.0
| JPT | 97.3 | 2.7 | 0.0
| YRI | 99.3 | 0.7 | 0.0
| ASW | 98.2 | 1.8 | 0.0
| CHB | 98.5 | 1.5 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 98.0 | 2.0 | 0.0
| LWK | 96.4 | 3.6 | 0.0
| MEX | 93.0 | 7.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 89.8 | 9.2 | 1.0
| HapMapRevision=28
}}{{omim
|id=107690
|rsnum=5110
|variant=0001
}}

{{ClinVar
|rsid=5110
|Reversed=1
|FwdREF=G
|FwdALT=T
|REF=C
|ALT=A
|RSPOS=116691634
|CHROM=11
|GMAF=0.033
|dbSNPBuildID=52
|SSR=0
|SAO=1
|VP=0x050178000000150517110100
|GENEINFO=APOA4:337
|GENE_NAME=APOA4
|GENE_ID=337
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000011.9:g.116691634C>A
|CLNORIGIN=1
|CLNSIG=2
|Tags=RV;PM;TPA;PMC;SLO;VLD;G5;HD;GNO;KGPhase1;KGPROD;OTHERKG;PH3;LSD;OM
|CAF=0.9669; 0.03306
|CLNACC=RCV000019494.1
|CLNDBN=APOLIPOPROTEIN A-IV POLYMORPHISM, APOA4*1/APOA4*2
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=107690.0001
|COMMON=1
|Disease=APOLIPOPROTEIN A-IV POLYMORPHISM
}}

{{PMID Auto
|PMID=18513389
|Title=New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background.
|OA=1
}}

{{PMID Auto
|PMID=19041386
|Title=Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.
|OA=1
}}

{{PMID Auto
|PMID=19057464
|Title=Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
|OA=1
}}

{{PMID Auto
|PMID=19131662
|Title=A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients.
|OA=1
}}

{{PMID Auto
|PMID=19263529
|Title=Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach.
|OA=1
}}

{{GET Evidence
|gene=APOA4
|aa_change=Gln380His
|aa_change_short=Q380H
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs5110
|overall_frequency_n=625
|overall_frequency_d=10754
|overall_frequency=0.0581179
|n_genomes=3
|n_genomes_annotated=0
|n_haplomes=3
|n_articles=0
|n_articles_annotated=0
|nblosum100=-1
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}